NL2001552A1 - Rage fusion proteins, preparations and methods for their use. - Google Patents

Rage fusion proteins, preparations and methods for their use.

Info

Publication number
NL2001552A1
NL2001552A1 NL2001552A NL2001552A NL2001552A1 NL 2001552 A1 NL2001552 A1 NL 2001552A1 NL 2001552 A NL2001552 A NL 2001552A NL 2001552 A NL2001552 A NL 2001552A NL 2001552 A1 NL2001552 A1 NL 2001552A1
Authority
NL
Netherlands
Prior art keywords
preparations
methods
fusion proteins
rage fusion
rage
Prior art date
Application number
NL2001552A
Other languages
Dutch (nl)
Other versions
NL2001552C2 (en
Inventor
Adnan M M Mjalli
Robert Rothlein
Ye Edward Tian
Jeffrey C Webster
Eric J Benjamin
Original Assignee
Transtech Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transtech Pharma filed Critical Transtech Pharma
Priority to NL2001552A priority Critical patent/NL2001552C2/en
Publication of NL2001552A1 publication Critical patent/NL2001552A1/en
Application granted granted Critical
Publication of NL2001552C2 publication Critical patent/NL2001552C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
NL2001552A 2008-05-06 2008-05-06 New Receptor for Advanced Glycated Endproducts (RAGE) fusion protein and nucleic acids, useful for treating a RAGE-mediated disorder, e.g. amyloidosis, Alzheimer's disease, cancer, kidney failure, or inflammation NL2001552C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL2001552A NL2001552C2 (en) 2008-05-06 2008-05-06 New Receptor for Advanced Glycated Endproducts (RAGE) fusion protein and nucleic acids, useful for treating a RAGE-mediated disorder, e.g. amyloidosis, Alzheimer's disease, cancer, kidney failure, or inflammation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2001552A NL2001552C2 (en) 2008-05-06 2008-05-06 New Receptor for Advanced Glycated Endproducts (RAGE) fusion protein and nucleic acids, useful for treating a RAGE-mediated disorder, e.g. amyloidosis, Alzheimer's disease, cancer, kidney failure, or inflammation
NL2001552 2008-05-06

Publications (2)

Publication Number Publication Date
NL2001552A1 true NL2001552A1 (en) 2008-12-08
NL2001552C2 NL2001552C2 (en) 2009-05-07

Family

ID=40329339

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2001552A NL2001552C2 (en) 2008-05-06 2008-05-06 New Receptor for Advanced Glycated Endproducts (RAGE) fusion protein and nucleic acids, useful for treating a RAGE-mediated disorder, e.g. amyloidosis, Alzheimer's disease, cancer, kidney failure, or inflammation

Country Status (1)

Country Link
NL (1) NL2001552C2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981423B2 (en) * 2004-08-03 2011-07-19 Transtech Pharma, Inc. Rage fusion proteins
US20090060925A1 (en) * 2004-08-03 2009-03-05 The Trustees Of Columbia University In The City Of Rage Fusion Proteins and Methods of Use
NZ569545A (en) * 2006-02-09 2011-11-25 Transtech Pharma Inc Rage fusion proteins and methods of use for treating inflammation

Also Published As

Publication number Publication date
NL2001552C2 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
NL2000626A1 (en) Rage fusion proteins, preparations and methods for their use.
NL2000476A1 (en) Rage fusion proteins and methods for their use.
LTC2307454I2 (en) Stable and soluble antibodies that inhibit VEGF
BRPI0813452A2 (en) rage fusion proteins.
BRPI0916829A2 (en) axmi-115, axmi-113, axmi-005, axmi-13 and axmi-184; insecticidal proteins and methods for their use.
LTC2358756I2 (en) HUMAN RELIABLE HUMAN ANTIBODIES PCSK9
BRPI0918947A2 (en) antibody fusion protein
BRPI1008740A2 (en) Pesticide proteins and methods for their use.
BRPI0813216A2 (en) PROTEIN KINASE INHIBITORS AND METHODS FOR USING THEM.
ATE524493T1 (en) EXENDIN FUSION PROTEINS
BRPI0716744A2 (en) albumin fusion proteins
BRPI1011760A2 (en) method for preventing or reducing coagulation in the upper gastrointestinal tract of an individual, and use of anticoagulant protein.
BRPI0807480A2 (en) CONNECTING, IMMUNOGLOBULIN G, COMPOSITION AND FUSION PROTEIN
DK2139987T5 (en) PROCEDURES FOR PROTEIN PREPARATION WITH ANTI-SENESCEN RELATIONS
DK2064334T3 (en) ALDEHYDAY, APPLICATIONS THEREOF IN SITE SPECIFIC PROTEIN MODIFICATION
CU23869B1 (en) ANTI-SCLEROSTIN ANTIBODIES AND FUNCTIONAL PROTEINS
BRPI0819714A2 (en) Protein formulations and production methods thereof.
DK2209375T3 (en) PARP-INHIBITOR RELATIONS, PREPARATIONS AND PROCEDURES FOR USE THEREOF
BRPI0814085A2 (en) SYSTEM AND METHOD
BRPI0815101A2 (en) METHOD AND SYSTEM
BRPI0822219A2 (en) NUCLEIC ACIDS OF AMINOTRANSFERASE AND OXIDOREDUCTASE AND POLYPEPTIDES AND METHODS OF USE.
DK2252633T3 (en) Anti-TrkA antibodies and derivatives thereof
BRPI0810963A2 (en) system and method
DK1988090T3 (en) IMIDAZOLE-5-CARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR PREPARING THESE AND USE THEREOF
DK1976884T3 (en) Anti-ephrinb2 antibodies and methods for their use.

Legal Events

Date Code Title Description
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20090303

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20101201